
Sai Life Sciences upgraded to IND AA by India Ratings on bank loans
India Ratings raised the long-term rating on the company's rated bank loans to IND AA with a Stable Outlook, while capex of ₹1,100 crore to ₹1,300 crore planned for FY27 is flagged as a watch point.
- Credit rating
- Pharmaceutical CRO/CDMO